What You Should Know:
- The U.S. Department of Health and Human Services (HHS) announced it is taking immediate action to implement President Donald J. Trump’s Executive Order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.”
- Under the leadership of President Trump, HHS Secretary Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz, the Department has outlined specific targets for
Read More
Technology
Trump Budget Would Strip Medicaid from 1.2M Restaurant Workers
What You Should Know:
- As discussions around significant federal budget changes continue, a new report from One Fair Wage details the potentially severe consequences of proposed Medicaid cuts for low-wage restaurant and tipped workers.
- The report, "Serving While Sick: The Effect of Trump Medicaid and Benefits Cuts on Restaurant Workers & Public Health," released in May 2025, argues that these cuts could strip healthcare from over a million vulnerable workers, forcing
Read More
Telehealth: An Essential Bridge to Healthcare Equity for Rural Communities
Rural America faces a unique set of healthcare challenges. While 20% of Americans live in rural communities, only 10% of physicians practice in those areas, leading to shortages that drastically limit access to care. With the United States expecting to face a shortage of up to 86,000 physicians over the next decade and over half of the rural physician workforce already over the age of 55, these gaps are at risk of worsening over the coming years without the proper solutions to address
Read More
Trump Signs Executive Order to Lower US Drug Prices with MFN Policy
What You Should Know:
- President Donald J. Trump has signed a new Executive Order aimed at bringing the prices Americans and U.S. taxpayers pay for prescription drugs in line with those paid by comparable developed nations.
- The executive order introduces a "Most-Favored-Nation" (MFN) pricing model and directs multiple government agencies to take action against what the Administration terms unfair international pricing practices that inflate costs for American
Read More
AI Study Challenges Fears of Racial Bias in Prostate Cancer Care
What You Should Know:
- Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
- The study rigorously assessed Artera's MMAI model and confirmed its ability to perform similarly across different racial subgroups using data from diverse prostate cancer clinical trials.
Addressing the Challenge of AI Racial Bias
Read More
AI Shows Promise in Detecting Overlooked Breast Cancers Between Screenings, UCLA Study Reveals
What You Should Know:
- Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging to treat, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
- The research suggests that integrating AI into breast cancer screening practices could lead to earlier treatment and improved
Read More
A Beginner’s Guide to Red Light Therapy
If you follow beauty influencers on social media, you may have seen them wearing a face mask that emits intense red light on the surface of their face. That is one of the popular examples of red light therapy. It is believed to improve skin health and fight various signs of aging. Before learning more about the benefits of such a therapy, let’s understand the basics first.
What is Red Light Therapy?
Red light therapy, also known as photobiomodulation, is an advanced treatment procedure
Read More
Mayo Clinic Study: Genetic Test Can Predict GLP-1 Nausea Side Effects
What You Should Know:
- A new study from Mayo Clinic, released this past weekend, signals a significant advancement in understanding and potentially mitigating the challenging side effects associated with popular GLP-1 agonist medications like Wegovy and Zepbound.
- Led by Mayo Clinic physician and obesity expert Andres Acosta, MD, PhD, the research reveals that it is now possible to predict which patients are most likely to experience gastrointestinal (GI) side effects,
Read More
AI Assistant Shows Promise in Easing Value-Based Care Burdens for Physicians, Study Finds
What You Should Know:
- A year-long study by Phyx Primary Care, a non-profit innovation lab, has revealed that an AI Assistant can significantly help physicians navigate the complexities of value-based care (VBC) while simultaneously reducing associated administrative burdens and burnout.
- The research evaluated Navina’s AI Copilot, a tool designed to synthesize fragmented patient data into actionable insights at the point of care, supporting clinical decision-making,
Read More
Vitable Health Acquires Liferaft’s HRA Platform to Tackle Small Business Healthcare Crisis
What You Shoiuld Know:
- Vitable Health, a prominent all-in-one health benefits platform announced its strategic acquisition of Liferaft's Health Reimbursement Arrangement (HRA) platform.
- The strategic acqusition positions Vitable Health to launch what it describes as the first unified platform aimed at solving the "Impossible Triangle" of employee healthcare – balancing cost, coverage, and administrative burden – particularly for small to medium-sized businesses
Read More
